In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

GlaxoSmithKline takes 9.9% stake in Korea's Dong-A Pharma

Executive Summary

Leading South Korean pharmaceutical firm Dong-A Pharmaceutical Co. Ltd. is teaming up with GlaxoSmithKline PLC to co-promote in Korea primary care drugs from each company's portfolio. Concurrently the Big Pharma has acquired a 9.9% stake in Dong-A for £73.9mm ($110.3mm).
Deal Industry
  • Pharmaceuticals
  • Pharmaceuticals
    • Generic Drugs
    • OTC, Consumer
Deal Status
  • Final
Deal Type
  • Alliance
    • Co-Promotion
    • Includes Equity
    • R&D and Marketing (Licensing)

Related Companies